Actionable news
0
All posts from Actionable news
Actionable news in GES: GUESS? Inc,

12 Biggest Mid-Day Losers For Thursday

  • Heat Biologics Inc HTBX 62.37% shares tumbled 55.9 percent to $1.27 following a negative outcome of its bladder cancer study. Heat Biologics said its phase 2 trial of Vesigenurtacel-L (HS-410) in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC) failed to meet primary endpoint.

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.